Device for detecting statin-associated myopathy through single nucleotide polymorphism rs976754 and application

A single nucleotide polymorphism and detection device technology, applied in the field of molecular biology, can solve the problems of insufficient evidence and limited effect, and achieve the effects of improving the quality of life, reducing adverse drug reactions, and improving the quality of life of patients
CN110438217AActive Publication Date: 2019-11-12BEIJING TIANTAN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV
2 Cites 1 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
BEIJING TIANTAN HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV
Publication Date
2019-11-12

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention provides a statin-associated myopathy detecting device. The device performs Massarray SNP genotyping detection in accordance with a single nucleotide polymorphism site rs976754 of a sample to be detected. The device comprises the following composition mechanisms of a primer synthesizing mechanism, a sample detection quantifying mechanism, a PCR reaction mechanism, a single-base extension reaction mechanism and a computer detection and analysis mechanism. The genotype at the site has important directive significance in recognizing myopathy high-risk crowds and adjusting medicationat the early stage, and has important significance in screening myopathy risk genes at the early stage, forecasting the myopathy generation risk, providing individualized medication guidance, reducing the generation of adverse drug reactions, performing prognosis and outcome of primary diseases, and improving the life quality of patients needing to take statin type blood lipid reducing medicines.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of molecular biology, and in particular relates to a single nucleotide polymorphism rs976754 detection device and application for statin-related myopathy. Background technique

[0002] Intracranial atherosclerosis is an independent risk factor for ischemic cerebrovascular disease, and hyperlipidemia can promote the formation of atherosclerotic plaque. Atorvastatin, as the first-line drug for lipid-lowering therapy, can competitively inhibit the rate-limiting enzyme 3-hydroxy-methylglutaryl CoA (HMG-CoA) reductase in cholesterol synthesis. Cholesterol synthesis is reduced, and at the same time, it promotes the increase of concentration-dependent LDL receptor activity, accelerates the catabolism of LDL, thereby significantly reducing blood lipid levels and stabilizing plaques, which is very beneficial to the prevention of ischemic cerebrovascular diseases.

[0003] Usually the use of atorvastatin is effective and safe,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More